Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 7, 2018
Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD)
Anna S Nikonova, Alexander Y Deneka, Anna A Kiseleva, et al.
Molecular Cancer Therapeutics
|
December 7, 2011
Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy
Weiwen Ying, Zhenjian Du, Lijun Sun, et al.
Angiogenesis
|
July 11, 2013
Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3
Ganji Purnachandra Nagaraju, Purnachandra Nagaraju Ganji, Wungki Park, et al.
AIDS (London, England)
|
June 17, 1999
Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero
O A Olivero, G M Shearer, C A Chougnet, et al.
Molecular Cancer Therapeutics
|
May 28, 2021
Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer Models
Danlin Sun, Anna S Nikonova, Peishan Zhang, et al.
Oncogene
|
June 23, 2015
Resistance to HSP90 inhibition involving loss of MCL1 addiction
S Busacca, E W P Law, I R Powley, et al.
Blood
|
July 24, 2010
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias
Hima Bansal, Sanjay Bansal, Manjeet Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2016
A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
Anna V Gaponova, Anna S Nikonova, Alexander Deneka, et al.
Molecular Cancer Therapeutics
|
August 15, 2015
HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors
David A Proia, Donald L Smith, Junyi Zhang, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 27, 2024
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 7, 2018
Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD)
Anna S Nikonova, Alexander Y Deneka, Anna A Kiseleva, et al.
Molecular Cancer Therapeutics
|
December 7, 2011
Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy
Weiwen Ying, Zhenjian Du, Lijun Sun, et al.
Angiogenesis
|
July 11, 2013
Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3
Ganji Purnachandra Nagaraju, Purnachandra Nagaraju Ganji, Wungki Park, et al.
AIDS (London, England)
|
June 17, 1999
Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero
O A Olivero, G M Shearer, C A Chougnet, et al.
Molecular Cancer Therapeutics
|
May 28, 2021
Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer Models
Danlin Sun, Anna S Nikonova, Peishan Zhang, et al.
Oncogene
|
June 23, 2015
Resistance to HSP90 inhibition involving loss of MCL1 addiction
S Busacca, E W P Law, I R Powley, et al.
Blood
|
July 24, 2010
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias
Hima Bansal, Sanjay Bansal, Manjeet Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2016
A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
Anna V Gaponova, Anna S Nikonova, Alexander Deneka, et al.
Molecular Cancer Therapeutics
|
August 15, 2015
HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors
David A Proia, Donald L Smith, Junyi Zhang, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 27, 2024
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, et al.
Page
of 9